FIELD: medicine.
SUBSTANCE: method involves application of multipotent mesenchymal stem cells (MMSC), obtained from allogeneic fragments of the human cadaver eyes scleral sulcus. 3D cell spheroids, 1000 cells in each spheroid, are created from these cells. 250 to 500 spheroids in 1 ml of a sterile 0.9% solution of sodium chloride are administered once parabulbarically.
EFFECT: method allows to improve and stabilise visual functions, to provide anti-apoptotic action, to prevent involvement of intact ganglion retinal cells in the apoptosis process due to a prolonged and stable secretion of neurotrophic factors by 3D-cell spheroids of multipotent mesenchymal stem cells.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2576785C1 |
| METHOD OF TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2578953C1 |
| METHOD OF THE TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2022 |
|
RU2801496C1 |
| METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 |
|
RU2622759C1 |
| METHOD FOR ASSESSING THE EFFICACY OF NEURORETINOPROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA ON BASIS OF DETERMINING RATIO OF NEURAL MARKERS | 2018 |
|
RU2681654C1 |
| METHOD OF EVALUATING STATE OF OPTIC NERVE IN OPTIC NEUROPATHY OF VARIOUS GENESES | 2015 |
|
RU2585429C1 |
| METHOD FOR TREATING ANTERIOR ISCHEMIC OPTIC NEUROPATHY WITH OPTIC DISC DRUSEN | 2023 |
|
RU2807392C1 |
| IMPLANT FOR POSTERIOR POLE REVASCULARISATION IN PATIENTS WITH GLAUCOMA | 2014 |
|
RU2557915C1 |
| METHOD FOR REPEAT MICROPULSE TRANSSCLERAL CYCLOPHOTOCOAGULATION IN VARIOUS STAGES OF REFRACTORY GLAUCOMA | 2021 |
|
RU2779993C1 |
| METHOD OF DINAMICAL SIZEMETRY OF RETINAL VESSELS | 2008 |
|
RU2393755C2 |
